$
0. 00
0
0%
$
2.32K Market Cap
- P/E Ratio
- Div Yield
15,039 Volume
- Eps
$ 0
Previous Close Want to track KHRNF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Khiron Life Sciences Corp. (KHRNF) Statistics
Valuation metrics
Market Cap 2.32K
Enterprise value 2.6M
Trailing P/E (ttm) -0.2
Forward P/E -
PEG ratio -0
Price/Sales (ttm) 0.73
Price/Book (mrq) 0.2
Enterprise Value/Revenue 0.2
Enterprise Value/EBITDA -0.12
Overview
Shares outstanding 217.14M
Float 204.94M
Shares short -
% Held by insiders -
% Held by institutions 0%
Average volume (10 days) 3.81K
Average volume (90 days) 5.22K
Price summary
52-Week low 0
52-Week high 0
Beta 20.88
50-Day moving average 0
200-Day moving average 0
Financials
Fiscal year
Fiscal year ends 31 Dec 2021
Most recent quarter (mrq) 30 Sep 2022
Profitability
Profit margin -2.59%
Operating margin -1.75%
Operational effectiveness
Return on assets -0.78%
Return on equity -0.69%
Income Statement
Revenue (ttm) 11.68M
Revenue per share (ttm) 0.08
Quarterly revenue growth (yoy) -0.04%
Gross profit (ttm) 4.83M
EBITDA -11.87M
Net income to common (ttm) -22.19M
Diluted EPS (ttm) -0.2
Quarterly earnings growth (yoy) -0.04%
Balance Sheet
Total cash (mrq) 1.4M
Total cash per share (mrq) 0.05
Total debt (mrq) 1.86M
Total Debt/Equity (mrq) 0.07
Current ratio (mrq) 3.08%
Book value per share (mrq) 0.2
Cash Flow
Cash flow statement -10.86M
Levered free cash flow (LFCF) -6.39M
